Bristol-Myers Again Rebuffs Plavix Fraud Claims

By Sam Schulz · January 8, 2008, 12:00 AM EST

Under fire from investors who insist they've sufficiently pled scienter, Bristol-Myers Squibb Co. is bolstering its bid to toss the suit that says it misled shareholders with the Plavix patent deal,...

To view the full article, register now.